Please login to the form below

Not currently logged in
Email:
Password:

Medivir appoints Actelion's Henric Juserius to senior commercial role

As executive vice president, commercial he will head up all the company's activities in the area

Medivir has appointed Actelion's Henric Juserius to head up its commercial activities and join its management team.

Juserius will move to the Swedish specialty pharma company in August from Actelion, where he was most recently commercial director for the Nordic region.

He has more than 20 years' experience in pharmaceutical marketing and sales, gained from companies such as Astra, GlaxoWellcome, Pfizer, Serono and Actelion.

Maris Hartmanis, Medivir's president and CEO, said: "I am very pleased to welcome Henric Juserius to Medivir as executive vice president, commercial.

“His extensive experience and broad expertise in marketing and sales of prescription drugs from both large and small pharmaceutical companies will be invaluable now that Medivir is approaching a market launch in the Nordic countries of its flagship product for hepatitis C, TMC435.”

The drug is a novel protease inhibitor in phase III clinical trials for hepatitis C that Medivir is developing in collaboration with Janssen Pharmaceuticals.

Meanwhile, the firm's first product, OTC cold sore treatment Xerese/Xerclear, is approved in Europe, where Medivir is launching it in partnership with GlaxoSmithKline.

15th May 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics